- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 279/04 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
Patent holdings for IPC class C07C 279/04
Total number of patents in this class: 83
10-year publication summary
12
|
9
|
7
|
3
|
4
|
6
|
3
|
0
|
6
|
4
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Immunomet Therapeutics Inc. | 31 |
6 |
Ramot at Tel-Aviv University Ltd. | 1477 |
5 |
Monsanto Technology LLC | 8317 |
4 |
Emory University | 1622 |
4 |
BASF SE | 20940 |
3 |
Lantheus Medical Imaging, Inc. | 177 |
3 |
Sika Technology AG | 2867 |
3 |
3m Innovative Properties Company | 17823 |
2 |
Flamel Technologies | 27 |
2 |
King Abdulaziz University | 510 |
2 |
The Penn State Research Foundation | 1527 |
2 |
Philipps-universitat Marburg | 105 |
2 |
San-Apro Limited | 77 |
2 |
Sanford-Burnham Medical Research Institute | 126 |
2 |
Waters Technologies Corporation | 1697 |
2 |
Murata Manufacturing Co., Ltd. | 24603 |
1 |
The Regents of the University of Michigan | 4711 |
1 |
The General Hospital Corporation | 4740 |
1 |
Tsinghua University | 5940 |
1 |
President and Fellows of Harvard College | 5986 |
1 |
Other owners | 34 |